1. 12-month outcome after cardiac surgery: prediction by troponin T in combination with the European system for cardiac operative risk evaluation.
- Author
-
Lurati Buse GA, Koller MT, Grapow M, Brüni CM, Kasper J, Seeberger MD, and Filipovic M
- Subjects
- Aged, Biomarkers blood, Female, Follow-Up Studies, Heart Diseases blood, Humans, Male, Middle Aged, Morbidity trends, Postoperative Complications blood, Postoperative Complications diagnosis, Prognosis, Prospective Studies, Risk Factors, Survival Rate trends, Switzerland epidemiology, Time Factors, Cardiac Surgical Procedures methods, Heart Diseases surgery, Postoperative Complications epidemiology, Risk Assessment methods, Severity of Illness Index, Troponin T blood
- Abstract
Background: The prognostic value of troponin T for midterm outcome in cardiac surgery is insufficiently known. We aimed to assess the value of troponin T to predict 12-month outcome after cardiac surgery, as a single predictor and in combination with the European system for cardiac operative risk evaluation (EuroSCORE)., Methods: This cohort study included consecutive patients undergoing on-pump cardiac surgery between January 2005 and December 2006. We evaluated postoperative troponin T (TNT) on days 1 and 2 and the EuroSCORE as predictor variables. The primary composite endpoint was all-cause mortality or any major adverse cardiac event (MACE) at 12 months. Logistic regression was used to study the prognostic effect of TNT in a univariate analysis and after adjustment for EuroSCORE. The area under the receiver-operator curve (AUC) was calculated to report the discriminatory performance of the models., Results: Seven hundred forty-one patients were available for analysis. Within 12 months after surgery, 92 (12.4%) patients had a MACE, 48 (6.5%) of whom died. A multivariate model of continuous TNT and the continuous logistic EuroSCORE showed a significant independent association between TNT and the composite endpoint (odds ratio [OR] 1.03, 95% confidence interval [CI] 1.02 to 1.04 per 0.1 microg/L increase in TNT). The AUC for the prediction of the composite endpoint of the model combining TNT and the EuroSCORE was 0.72; when based on EuroSCORE alone it was 0.64 (p < 0.0001)., Conclusions: Postoperative TNT increase (per 0.1 microg/L) is a strong independent predictor of 12-month outcome after on-pump cardiac surgery. Updating the preoperative EuroSCORE risk with postoperative TNT allows for better prediction of 12-month MACE and all-cause mortality.
- Published
- 2009
- Full Text
- View/download PDF